Windward Bio Shares Jump 68% Above IPO Price on First Trading Day
Windward Bio priced its IPO at $17 per share and closed its first trading day at $28.50, 68% higher. The shares began trading on Nasdaq on November 13.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Windward Bio set its IPO price at $17 per share. On its first trading day the stock closed at $28.50, 68% above the offering price. According to TradingView, citing the company's press release, the market capitalization at the close was approximately $1.69 billion.
The shares started trading on Nasdaq on November 13, 2026. The company is a clinical-stage biotech, and its pipeline remains in clinical development.
why it matters
The strong debut points to solid investor demand for the clinical-stage biotech. Whether the premium to the offering price holds will become clearer in later sessions, while clinical trial progress would be the next key driver.
market impact
Windward Bio shares: a strong first trading day signals investor interest in the stock
tags
instruments
sources
- Windward Bio Shares Close 68% Above $17 IPO Price — TradingView, 14 November 2026 at 03:13 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗